A Bullock County woman filed a lawsuit June 3 against Wyeth Pharmaceuticals of New Jersey and Qualitest Pharmaceuticals of Alabama for allegedly causing her to develop breast cancer by falsely promoting hormone therapy medication.
A Bullock County woman filed a lawsuit June 3 against Wyeth Pharmaceuticals and Qualitest Pharmaceuticals of Alabama for allegedly causing her to develop breast cancer by falsely promoting hormone therapy medication.
The law firm of Barbour County native Jere Beasley is representing an Alabama resident who is suing New Jersey-based Wyeth Pharmaceuticals and Alabama-based Qualitest for allegedly causing physical injury, including breast cancer.
The law firm of Barbour County native Jere Beasley is representing an Alabama resident who is suing New Jersey-based Wyeth Pharmaceuticals and Alabama-based Qualitist for allegedly causing physical injury, including breast cancer.
Bullock County Circuit court in Union Springs will be the venue for the state's first lawsuit against pharmaceutical manufacturers of three hormone therapy drugs.
A lawsuit was filed on behalf of an Alabama resident against New Jersey-based Wyeth Pharmaceuticals and Alabama-based Qualitist for allegedly causing physical injury, including breast cancer.
A new report adds weight to the idea that recurring breast cancer may be related to which hormones are used in therapy for women after menopause.
A new study suggests that the composition of hormone replacement therapy is a factor in determining whether it increases the risk of breast cancer recurrence.
Doctors should not recommend that post-menopausal women start hormone replacement therapy (HRT) just to prevent cardiovascular events.
The FDA is giving important new safety advice to postmenopausal women and their health-care providers concerning drug products that contain estrogen.
